Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients

de, Lafuente Yanina; García, Mónica Cristina; Jiminez-Kairuz, Alvaro

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients

Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro

Issue: Jul/Aug 2019 - Volume 23, Number 4
View All Articles in Issue

Page(s): 324-331

Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Page 1

Download in electronic PDF format for $65

Abstract: Indomethacin is used for off-label prescription for the treatment of patent ductus arteriosus in premature infants. In Argentina, indomethacin is only available as a suppository, dermic cream, injectable ampules, and delayed-release capsules. Aiming to improve pediatric treatment and minimize the risk associated with improper dosage, this work focused on the development of an extemporaneous 0.2% indomethacin oral suspension, starting from the commercially injectable formulation. Two 150-mL batches of suspension were prepared using Generally Recognized as Safe excipients. The suspensions were stored for 17 days at room temperature. Physical stability, morphological analysis of suspended particles, sedimentation volume, easy re-suspension, and dynamic viscosity were studied. The indomethacin content, dissolution studies, and microbiological attributes of nonsterile pharmaceutical products were also evaluated. After 17 days of storage, the suspension was easily re-dispersed after 15 seconds of the hand-shaking technique. There were no detectable changes in color, odor, and/or flavor. The suspension showed minimal changes in pH, viscosity, shape, and mean size of the suspended indomethacin particles. The content uniformity and drug dissolution remained within the acceptable range during storage. This oral liquid suspension is an interesting alternative to be prepared by hospital pharmacy services for optimizing the pediatric treatment of patent ductus arteriosus.

Related Keywords: Yanina de Lafuente, PharmD, Mónica Cristina García, PhD, Alvaro Jiminez-Kairuz, PhD, indomethacin, nonsteroidal anti-inflammatory drug, NSAID, patent ductus arteriosus, neonates, physical stability, chemical stability

Related Categories: PEDIATRICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, CARDIOLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro	Jul/Aug 2019 Pg. 324-331
Pediatric Compounding: Coloring Outside the Lines Preckshot John	Jan/Feb 2001 Pg. 6-8
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora	Jan/Feb 2001 Pg. 9-12
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D	May/Jun 2003 Pg. 233-239
Indomethacin 1-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2013 Pg. 419
Indomethacin 2-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2006 Pg. 458
Compounding for the Pediatric Patient Allen Loyd V Jr	Mar/Apr 1997 Pg. 84-86
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel	Mar/Apr 2017 Pg. 160-163
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio	Jan/Feb 2023 Pg. 72-77
Treatment of Pain with a Topically Applied Combination of Indomethacin and Piroxicam Vetter Eric R, Curtis Lawrence	May/Jun 2002 Pg. 189-192
Indomethacin 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 543
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Allen Loyd V Jr	Nov/Dec 2008 Pg. 541
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis Choo Winnie	Jan/Feb 2016 Pg. 6-10
Indomethacin 1% Topical Gel Allen Loyd V Jr	Jul/Aug 2022 Pg. 325-326
Indomethacin Gel Allen Loyd V Jr	May/Jun 2016 Pg. 230
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N	Sep/Oct 2003 Pg. 389-393
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Fields Shannon W	Jan/Feb 2007 Pg. 26-27
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah	Mar/Apr 2010 Pg. 165-170